Finorify

AMGN

Amgen Inc.

$414.61+2.11%

Price

AMGN daily closing price
Market cap
$224.14 billion
P/E (TTM)
25.77
EV/EBITDA
16.38
52W range
$271.18 – $444.12
Div yield
2.36%
Volume
1.8M
Sector
Healthcare

Amgen Inc. (AMGN) last closed at $414.61, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for AMGN, covered for search and blurred for visitors.

Performance

  • 1D-0.14%
  • 5D+2.87%
  • 1M+6.85%
  • 3M+17.99%
  • 6M+26.72%
  • 1Y+44.51%
  • 5Y+115.28%

Financials

AMGN revenueQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, Amgen Inc. reported revenue of $38.09 billion.

The prior window totaled $34.92 billion, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $12.48 billion.

Free cash flow in the latest window was $10.18 billion.

These amounts are taken from Amgen Inc.'s SEC filings and are a snapshot as of June 30, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 20.3% (74 of 100). Leverage: D/E 4.90× (0 of 100). Cash generation: FCF margin 26.7% (53 of 100). Net margin: 23.6% (59 of 100). Liquidity: Current 1.37× (69 of 100).

Cash Flow

AMGN free cash flowQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Margins

AMGN operating margin

Valuation

P/E (TTM)
25.77
P/S (TTM)
5.88
EV/EBITDA
16.38

Insights

Finorify has not written notes for AMGN in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open AMGN in Finorify